Gareth Shaw, of Doceree, on healthcare pharma marketing

Life science companies can better manage online communications, says Gareth Shaw, of Doceree. Here he discusses the future of healthcare pharma marketing

Physician marketing is nowhere close to consumer marketing, both in terms of sophistication and leveraging technology to drive greater efficiency and returns on investment. This challenge inspired Harshit Jain, a physician-turned healthcare marketing veteran, to start Doceree. 

The Doceree platform enables pharma brands to engage with physicians and other health care providers effectively in the digital realm. Because life science companies are the core source of relevant information around any research in the medical field, Doceree acts as an enabler for the same. Using Doceree’s proprietary identity resolution technology ESPYIAN, life science brands can showcase the right information to the right physician at the most opportune moments. The company was founded in 2018 and is headquartered in New York. 

Responsible for Doceree’s UK and European operations, is Gareth Shaw. The father of two, from Buckinghamshire, England, started studying Pharmacology at university, but quickly realised he was more inclined towards business studies and switched degrees to Marketing. From there, Shaw took on roles at Yahoo and Experian, before beginning his career in healthcare five years ago, with healthcare marketing company PulsePoint.

I led the PulsePoint European operations and spent a year priming the UK healthcare market for programmatic marketing, before PulsePoint pulled out of Europe in 2018 and my role became US focussed,” explains Shaw. “In my current role, I am now back in the UK and Europe to finish what I started back in 2017.”

What is Doceree and how does it support physicians?

Doceree’s reception from the healthcare industry has been positive, especially in its attitude to digital adoption. 

“Five years ago, UK and European marketers and their agencies were beginning to show some interest in programmatic marketing, but lacked the knowledge, skillsets and most notable the industry-specific tools to deploy it,” said Shaw. “Today, five years on most players in the space are ready to commit to programmatic but until Doceree entered the market, they lacked the specialist tools to do so in the UK and Europe. This kind of response underscores the need and immense scope for innovative technologies in the life sciences domain, which has always been perceived as the category most apprehensive about digital adoption.”

Doceree’s ability to provide real-time data analytics enables marketers to deliver messages that have the greatest impact. When these moments are identified in the middle of a campaign, Doceree affords life science marketers with a platform to 

effortlessly target physicians with a relevant brand message by taking advantage of this real time data.

“Across endemic content and point-of-care networks, marketers need to capitalise on the moments when physicians are in the appropriate mindset to effectively engage with a brand message,” explains Shaw.

“Programmatic allows the use of real-time analytics to create greater engagements by serving them the right message at the right time. Whether it’s in a virtual waiting room or reading an online medical journal, moments during a physician’s professional activities are when messages need to pique their interest and align with when they’re in a mindset to absorb new medical information.”

This also allows Doceree to better understand the digital behaviours of high-performance computing so they can create more engaging digital experiences for them with their life science industry partners and clients. 

“Our platform is building greater efficiencies and helping brands optimise their ROI by using real-time data analytics efficiently,” said Shaw. 


Life science companies can better navigate online communications

Doceree has made it easier to reach out to high-performance computing on behalf of life sciences companies. 

“Until now, Rx communication was a complex labyrinth of multiple different media touchpoints and physical visits from medical personnel,” said Shaw. “With Doceree’s programmatic technology, life sciences companies can now reach and communicate their messaging to high-performance computing, all in a brand-safe and compliant manner. Rx communication can now happen across multiple digital touchpoints that HCPs are already visiting, offering several advantages over more traditional siloed tactics.”

In the US, Doceree can precisely identify HCPs on various endemic and point-of-care platforms, and based on their professional behavior traits (diagnoses, medications, & procedures they perform), deliver them relevant messaging from life science brands. All of this is powered by Doceree’s proprietary identity-resolution technology, ESPYIAN.

“In the UK and across the EU, after the advent of GDPR, such precise 1:1 physician-level targeting may not be possible,” says Shaw. “But ESPYIAN lets us target physicians at speciality level, which makes it easy for life science brands to reach HCP audiences based on the HCPs speciality at scale with highly relevant messaging.

“In terms of performance measurement, our US offering can provide script lift measurement studies at an individual physician level. Owing to similar GDPR-led constraints, our UK script lift offering will be able to provide script lift measurement studies at a practice location level. We’re also exploring behavioural lift measurement offerings globally.”


The future of healthcare pharma marketing at Doceree

Over the next year, there is a lot of excitement ahead as Doceree grows its team across Europe and expands its product suite to provide clients and partners with market leading insights, activation and measurement tools, custom built for the healthcare vertical. AI will have a role to play in that. 

“Data is the modern-day oil and powers the digital world,” said Shaw. “AI and machine learning are the tools we use to refine data into powerful actionable insights that deliver positive valuable engagement between life sciences brands and physicians.”

Yet like all healthcare services and platforms, Doceree is aware of the threats of cybercrime and is determined to stay ahead of those who seek to exploit the healthcare industry.

“We have put in place appropriate security measures to prevent personal data from being accidentally lost, used or accessed in an unauthorised way, altered or disclosed,” said Shaw. “In addition, we limit access to data to those employees, agents, contractors and other third parties who have a business need. They only process data on our instructions and they are subject to a duty of confidentiality.

“At Doceree, customer trust is our top priority. Doceree monitors the evolving privacy, regulatory and legislative landscape to identify changes and determine what tools are needed to meet compliance requirements. We use the industry-leading encryption features to protect our content in transit and at rest while using our own encryption keys. Our VPN and SSO-enabled environment give us flexibility, security and reliability. We have put in place procedures to deal with any suspected personal data breach,” concludes Shaw.


Featured Articles

Cancer Vaccines Breakthrough a Glimpse of Healthcare Future

As the UK's NHS becomes the first healthcare provider to launch a cancer vaccine testing programme, we explore this groundbreaking oncological treatment

Change Healthcare Cyberattack Fallout Continues

Three months on, the cyberattack on UnitedHealth Group's Change Healthcare is still affecting US citizens, with delays and

McKinsey: National E-health Initiatives on the Rise

McKinsey report on countries that are scaling national e-health programmes says it is easing financial pressures on healthcare systems globally

Edwards Lifesciences: a Profile of the Heart Tech Specialist

Medical Devices & Pharma

London Hospitals Cyberattack Wreaks Healthcare Havoc

Technology & AI

Healthcare Provision in India: Challenges and Opportunities

Health Insurance & Finance